Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsutaro Hamano

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 3, 2020
[Using Real World Data in Cancer Clinical Studies]Takeharu Yamanaka, Kentaro Yamazaki, Tetsutaro Hamano
Trials|July 26, 2013
Effects of Anma massage therapy (Japanese massage) for gynecological cancer survivors: study protocol for a randomized controlled trialNozomi Donoyama, Toyomi Satoh, Tetsutaro Hamano
Plos One|May 4, 2018
Effects of Anma therapy (Japanese massage) on health-related quality of life in gynecologic cancer survivors: A randomized controlled trialNozomi Donoyama, Toyomi Satoh, Tetsutaro Hamano, et al.
Gynecologic Oncology|July 20, 2016
Physical effects of Anma therapy (Japanese massage) for gynecologic cancer survivors: A randomized controlled trialNozomi Donoyama, Toyomi Satoh, Tetsutaro Hamano, et al.
International Journal of Clinical Oncology|February 17, 2016
Identification of adverse events that have a negative impact on quality of life in a clinical trial comparing docetaxel versus S-1 with cisplatin in lung cancerEriko Aotani, Tetsutaro Hamano, Akihiko Gemma, et al.
Future Oncology (London, England)|June 30, 2023
Clinical outcomes of intensive versus less intensive first-line chemotherapy for metastatic colorectal cancerKentaro Yamazaki, Satoshi Yuki, Eiji Oki, et al.
Clinical Colorectal Cancer|April 20, 2021
Real-World Evidence on Second-Line Treatment of Metastatic Colorectal Cancer Using Fluoropyrimidine, Irinotecan, and Angiogenesis InhibitorKentaro Yamazaki, Satoshi Yuki, Eiji Oki, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 31, 2012
Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066)Takafumi Toita, Ryo Kitagawa, Tetsutaro Hamano, et al.
Gynecologic Oncology|May 5, 2012
Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose scheduleTakafumi Toita, Ryo Kitagawa, Tetsutaro Hamano, et al.
Cancer Science|March 25, 2010
Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancerTakako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 3, 2020
[Using Real World Data in Cancer Clinical Studies]Takeharu Yamanaka, Kentaro Yamazaki, Tetsutaro Hamano
Trials|July 26, 2013
Effects of Anma massage therapy (Japanese massage) for gynecological cancer survivors: study protocol for a randomized controlled trialNozomi Donoyama, Toyomi Satoh, Tetsutaro Hamano
Plos One|May 4, 2018
Effects of Anma therapy (Japanese massage) on health-related quality of life in gynecologic cancer survivors: A randomized controlled trialNozomi Donoyama, Toyomi Satoh, Tetsutaro Hamano, et al.
Gynecologic Oncology|July 20, 2016
Physical effects of Anma therapy (Japanese massage) for gynecologic cancer survivors: A randomized controlled trialNozomi Donoyama, Toyomi Satoh, Tetsutaro Hamano, et al.
International Journal of Clinical Oncology|February 17, 2016
Identification of adverse events that have a negative impact on quality of life in a clinical trial comparing docetaxel versus S-1 with cisplatin in lung cancerEriko Aotani, Tetsutaro Hamano, Akihiko Gemma, et al.
Future Oncology (London, England)|June 30, 2023
Clinical outcomes of intensive versus less intensive first-line chemotherapy for metastatic colorectal cancerKentaro Yamazaki, Satoshi Yuki, Eiji Oki, et al.
Clinical Colorectal Cancer|April 20, 2021
Real-World Evidence on Second-Line Treatment of Metastatic Colorectal Cancer Using Fluoropyrimidine, Irinotecan, and Angiogenesis InhibitorKentaro Yamazaki, Satoshi Yuki, Eiji Oki, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 31, 2012
Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066)Takafumi Toita, Ryo Kitagawa, Tetsutaro Hamano, et al.
Gynecologic Oncology|May 5, 2012
Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose scheduleTakafumi Toita, Ryo Kitagawa, Tetsutaro Hamano, et al.
Cancer Science|March 25, 2010
Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancerTakako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano, et al.
Pageof 3